US Patent Issued to TMEM16A on Sept. 29 for "Pyridine derivatives as TMEM16A modulators for use in the treatment of respiratory conditions" (British Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,212, issued on Sept. 29, was assigned to TMEM16A Ltd. (Welwyn Garden City, Great Britain).

"Pyridine derivatives as TMEM16A modulators for use in the treatment of respiratory conditions" was invented by Stephen Collingwood (Brighton, Great Britain), Craig Buxton (Abingdon, Great Britain), Jonathan David Hargrave (Abingdon, Great Britain), Peter Ingram (Abingdon, Great Britain), Thomas Beauregard Schofield (Abingdon, Great Britain), Abdul Shaikh (Abingdon, Great Britain) and Christopher Stimson (Abingdon, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds of general formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 ...